Company / Book Value per Share
ORAMED PHARMACEUTICALS INC. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.641
FY2025
5-year range
$3.626 / $4.89
FY2021-FY2025
Trend
+0.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from $1.116 in FY2020 to $4.89 in FY2021.
Based on SEC 10-K filings.
$3.641 in FY2025 with a 5-year CAGR of +26.7%.
Declined from $4.141 to $3.641 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -2.9%
- 5-Year CAGR
- +26.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +26.7%, indicating consistent growth.
- In FY2025, book value per share increased 0.4% year-over-year.
- Peak book value per share was recorded in FY2021.
- Lowest book value per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.641 | +0.4% |
| FY2024 | $3.626 | -12.4% |
| FY2023 | $4.141 | +4.1% |
| FY2022 | $3.978 | -18.6% |
| FY2021 | $4.89 | +338.3% |
| FY2020 | $1.116 | -37.7% |
| FY2019 | $1.791 | -6.5% |
| FY2018 | $1.916 | +1.7% |
| FY2017 | $1.883 | +4.7% |
| FY2016 | $1.798 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026